The Perelman School of Medicine at the University of Pennsylvania has introduced a revolutionary tool named MISO (Multi-modal Spatial Omics), which leverages artificial intelligence to significantly improve the detection and analysis of cell-level characteristics in cancer. This innovative tool
Per-and polyfluoroalkyl substances (PFAS) are synthetic chemicals that have been widely used since the 1940s due to their resistance to degradation. This characteristic has led to their persistent accumulation in the environment, particularly in drinking water. Recent research has raised concerns
The transformative potential of Artificial Intelligence (AI) in the field of therapeutics, particularly drug development, has been a topic of significant excitement and investment. However, despite the enthusiasm, tangible evidence of AI's success in revolutionizing drug development remains
Recent advancements in genetic testing have brought significant hope to families facing challenges related to fertility issues and genetic disorders. The Pioneers in Genetic Testing Innovative techniques in pre-implantation genetic testing (PGT) and non-invasive prenatal testing (NIPT) are
Clinical trials are the backbone of medical advancements, but they face a persistent challenge: participant adherence. Non-adherence can skew results, impact outcomes, and undermine the effectiveness of health solutions. Enter digital adherence tools, which are revolutionizing the landscape by
The production of protein-based drugs is a cornerstone of modern medicine, offering treatments for a range of conditions from cancer to autoimmune diseases. Central to this process are Chinese hamster ovary (CHO) cells, which are widely used in the biotechnology industry for their ability to